Literature DB >> 14612597

Neuropsychiatric non-motor aspects of Parkinson's disease.

B R Thanvi1, S K Munshi, N Vijaykumar, T C N Lo.   

Abstract

Parkinson's disease is often recognised as a motor disease characterised by rest tremor, rigidity, bradykinesia, and postural disturbances. However, there are several non-motor aspects of the disease that are of at least equal importance in the management of patients with Parkinson's disease. They include depression, cognitive impairment, anxiety, and psychosis among others. It is important to recognise them, as they are common and they contribute significantly to patients' morbidity, quality of life, and institutionalisation to long term care homes. In addition to the disease duration and severity, other factors including drugs may contribute to their occurrence. Pathogenesis of these aspects is not fully understood, though there has been a significant increase in the knowledge in recent years. Management of these aspects involves a multidisciplinary approach.

Entities:  

Mesh:

Year:  2003        PMID: 14612597      PMCID: PMC1742855          DOI: 10.1136/pmj.79.936.561

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  25 in total

Review 1.  Hallucinations in Parkinson's disease: the clinical syndrome.

Authors:  C G Goetz
Journal:  Adv Neurol       Date:  1999

2.  Depression in Parkinson's disease.

Authors:  H Allain; S Schuck; N Mauduit
Journal:  BMJ       Date:  2000-05-13

3.  Comorbidity of the nonmotor symptoms of Parkinson's disease.

Authors:  L M Shulman; R L Taback; J Bean; W J Weiner
Journal:  Mov Disord       Date:  2001-05       Impact factor: 10.338

4.  Risk of dementia in Parkinson's disease: a community-based, prospective study.

Authors:  D Aarsland; K Andersen; J P Larsen; A Lolk; H Nielsen; P Kragh-Sørensen
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

Review 5.  Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease.

Authors:  J R Slaughter; K A Slaughter; D Nichols; S E Holmes; M P Martens
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

Review 6.  Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates.

Authors:  J L Cummings
Journal:  J Geriatr Psychiatry Neurol       Date:  1988-01       Impact factor: 2.680

7.  [Depression and Parkinson's Disease: study of a series of 135 Parkinson's patients].

Authors:  A Anguenot; P Y Loll; J P Neau; P Ingrand; R Gil
Journal:  Can J Neurol Sci       Date:  2002-05       Impact factor: 2.104

Review 8.  Beyond the iron mask: towards better recognition and treatment of depression associated with Parkinson's disease.

Authors:  David J Burn
Journal:  Mov Disord       Date:  2002-05       Impact factor: 10.338

9.  Responsibility of extrastriatal areas for the appearance of psychotic symptoms (clinical and biochemical human post-mortem findings).

Authors:  W Birkmayer; P Riederer
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

10.  Depression in Parkinson's disease: a quantitative and qualitative analysis.

Authors:  A M Gotham; R G Brown; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-04       Impact factor: 10.154

View more
  14 in total

1.  Driving-Related Cognitive Performance in Older Adults with Pharmacologically Treated Cardiovascular Disease.

Authors:  Sarah Viamonte; David Vance; Virginia Wadley; Dan Roenker; Karlene Ball
Journal:  Clin Gerontol       Date:  2010-04-01       Impact factor: 2.619

Review 2.  Establishing a framework for neuropathological correlates and glymphatic system functioning in Parkinson's disease.

Authors:  Saranya Sundaram; Rachel L Hughes; Eric Peterson; Eva M Müller-Oehring; Helen M Brontë-Stewart; Kathleen L Poston; Afik Faerman; Chloe Bhowmick; Tilman Schulte
Journal:  Neurosci Biobehav Rev       Date:  2019-05-24       Impact factor: 8.989

Review 3.  Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.

Authors:  C Mehler-Wex; P Riederer; M Gerlach
Journal:  Neurotox Res       Date:  2006-12       Impact factor: 3.911

Review 4.  Psychosis in Parkinson's disease.

Authors:  B R Thanvi; T C N Lo; D P Harsh
Journal:  Postgrad Med J       Date:  2005-10       Impact factor: 2.401

5.  Frequency of cognitive impairment and depression in Parkinson's disease: A preliminary case-control study.

Authors:  Oluwadamilola O Ojo; Njideka U Okubadejo; Frank I Ojini; Mustapha A Danesi
Journal:  Niger Med J       Date:  2012-04

6.  Diminished activation of motor working-memory networks in Parkinson's disease.

Authors:  Claudia Rottschy; Alexandra Kleiman; Imis Dogan; Robert Langner; Shahram Mirzazade; Martin Kronenbuerger; Cornelius Werner; N Jon Shah; Jörg B Schulz; Simon B Eickhoff; Kathrin Reetz
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

Review 7.  Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases.

Authors:  Carlos Fernández-Moriano; Elena González-Burgos; M Pilar Gómez-Serranillos
Journal:  Oxid Med Cell Longev       Date:  2015-04-29       Impact factor: 6.543

Review 8.  Psychiatric aspects of Parkinson's disease.

Authors:  Sandeep Grover; Mansi Somaiya; Santhosh Kumar; Ajit Avasthi
Journal:  J Neurosci Rural Pract       Date:  2015-01

9.  Metacognitive Performance, the Tip-of-Tongue Experience, Is Not Disrupted in Parkinsonian Patients.

Authors:  Justin D Oh-Lee; Sarah M Szymkowicz; Stefanie L Smith; Hajime Otani
Journal:  Parkinsons Dis       Date:  2012-04-22

10.  The effects of dopamine on digit span in Parkinson's disease.

Authors:  Clara Warden; Jaclyn Hwang; Anisa Marshall; Michelle Fenesy; Kathleen L Poston
Journal:  J Clin Mov Disord       Date:  2016-03-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.